ResearcherJilin UniversityNo recent work listed
Wei Feng
Matched on ORCID iD 0000-0001-5375-6045; OpenAlex author ID A5100378269. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2013: 1 paper · 2014: none · 2015: 2 papers · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper
Papers 5
- MiR-216a-5p inhibits tumorigenesis in Pancreatic Cancer by targeting TPT1/mTORC1 and is mediated by LINC01133. Last author DOI 10.7150/ijbs.46822↗
- Ribosomal protein L34 promotes the proliferation, invasion and metastasis of pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.13269↗
- Survivin expression and serum levels in pancreatic cancer. Last author DOI 10.1186/s12957-015-0605-7↗
- mTOR inhibition induces EGFR feedback activation in association with its resistance to human pancreatic cancer. Co-author DOI 10.3390/ijms16023267↗
- miR-99b-targeted mTOR induction contributes to irradiation resistance in pancreatic cancer. Co-author DOI 10.1186/1476-4598-12-81↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yan Liu · 2 shared papers, 2013–2015 · strength 0.10
- Guangyi Wang · 2 shared papers, 2013–2015 · strength 0.10
- Jian Zhang · 1 shared paper, 2020 · strength 0.10
- Hongmei Wang · 1 shared paper, 2020 · strength 0.10
- Yan Liu · 1 shared paper, 2016 · strength 0.06
- Guoyue Lv · 1 shared paper, 2016 · strength 0.06
- He Dong · 1 shared paper, 2015 · strength 0.06
- Dong Chen · 1 shared paper, 2015 · strength 0.06
- Zifan Lu · 1 shared paper, 2013 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.